title: Review: in type 2 diabetes, GLP-1 agonists plus basal insulin reduce HbA1c without increasing hypoglycemia.
authors.forename: Naykky Singh
authors.initials: NS
authors.lastname: Ospina
authors.forename: Victor M
authors.initials: VM
authors.lastname: Montori
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D049528:Insulin, Long-Acting / Q000627:therapeutic use*; D018027:Receptors, Glucagon / Q000819:agonists*
chemical_list: D007004:Hypoglycemic Agents; D049528:Insulin, Long-Acting; D018027:Receptors, Glucagon